Streetbeat News

Equity Actions

JD

Investors have shown increased interest in JD.com (NASDAQ:JD) with a noticeable surge in options activity, indicating a split sentiment with 50% bullish and 50% bearish. The options trades suggest a target price range of $20.0 to $42.5. Notable trades include both puts and calls with varying sentiments and expiration dates. JD.com's current market performance shows a slight decrease in stock price, with an RSI suggesting it may be approaching overbought territory. Analysts have mixed ratings on JD, with target prices ranging from $26 to $55.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:31 pm

NOW

ServiceNow (NYSE:NOW) has seen significant options trading activity, with a bullish sentiment from financial giants. Analysis of 12 unusual trades revealed 66% bullish and 33% bearish tendencies. The trades include 8 puts valued at $416,626 and 4 calls worth $181,400, targeting a price range of $600 to $1180. The largest trades were bullish put sweeps with strike prices around $770-$785. ServiceNow, a SaaS provider for business process automation, has a current stock price of $784, up 0.7%, with an RSI indicating potential overbought status. Analysts have set an average price target of $880, with recent downgrades from Stifel and Keybanc.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:17 pm

IDAI

Trust Stamp reported a FY23 EPS of $(1.07), improving from $(2.55) YoY, with revenue decreasing to $4.56M from $5.39M. The reduction in revenue was attributed to the end of the ICE pilot and a shift towards SaaS sales, offset by a significant reduction in SG&A expenses. The company also reduced its operating loss to $7.64M from $12.08M YoY and strengthened its balance sheet through equity investments, raising a total of $10.32M. Trust Stamp continues to invest in R&D, boasting a portfolio of 20 issued patents and 15 pending, focusing on AI technology.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 2:02 pm

THC

Nine analysts have recently updated their ratings on Tenet Healthcare (NYSE:THC), showing a mix of bullish and somewhat bullish perspectives with no bearish views. The average 12-month price target for THC has been raised to $108.0, up 13.48% from the previous target of $95.17. Analyst actions include maintaining, raising, and announcing ratings with price targets ranging from $100.00 to $122.00. Tenet Healthcare, a Dallas-based healthcare services organization, has shown solid revenue growth and profitability but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

LEVI

Levi Strauss (NYSE:LEVI) has received mixed analyst ratings over the past three months, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for LEVI has increased to $18.83, up from $17.80, indicating a positive sentiment shift among analysts. Key financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA show Levi Strauss outperforming industry averages, suggesting a strong financial health and efficient management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

GME

GameStop Corp (NYSE:GME) shares fell after reporting Q4 revenue of $1.794 billion and adjusted earnings of 22 cents per share, both below analyst expectations. The company ended the quarter with $1.199 billion in cash and equivalents, and maintained limited long-term debt. No earnings call was held, continuing a trend for the fourth quarter. CFO Daniel Moore was promoted, and cost reduction measures were announced. Wedbush analyst Michael Pachter maintained an Underperform rating, lowering the price target from $6 to $5.60.

Portfolio Pulse from Adam Eckert

March 27, 2024 | 2:00 pm

GMDA

Gamida Cell Ltd. (NASDAQ:GMDA) shares plummeted after announcing a restructuring agreement with Highbridge Capital Management, aiming to provide financial stability and support for Omisirge's commercialization. The deal involves converting $75 million of debt into equity and injecting $30 million of new capital, making Gamida Cell a private entity wholly owned by Highbridge. The company's shares are expected to be canceled post-restructuring. Gamida Cell reported a net revenue of $1.8 million for FY23 and a reduced net loss compared to the previous year. The company also plans a 25% headcount reduction and will consolidate its operations in Israel.

Portfolio Pulse from Nabaparna Bhattacharya

March 27, 2024 | 1:42 pm

DJT

Jim Cramer commented on the overvaluation of Trump Media & Technology Group Corp (NASDAQ:DJT), which is trading on Nasdaq. He highlighted its trading pattern similar to a meme stock, with a valuation not grounded in its financial fundamentals. Cramer also mentioned that the stock serves as a 'keepsake' for Trump's supporters, potentially enabling Trump to raise more funds as the stock price increases. Despite the enthusiasm, experts caution investors about Trump's financial history and Truth Social's modest user base.

Portfolio Pulse from Benzinga Neuro

March 27, 2024 | 1:34 pm

AAPL

GME

TSLA

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin show little change despite bullish momentum, with a $160K price target for Bitcoin considered conservative. FTX seeks to nullify 'Sam Coins' amid bankruptcy. Dawkoins surges 400% on Richard Dawkins' birthday. GameStop and other stocks move lower in pre-market trading, while investor sentiment drops, affecting the S&P 500. Political and tech developments, including Tesla's Optimus robot and Apple's potential AI event, are highlighted. Financial and energy sectors also see significant news.

Portfolio Pulse from Akanksha Bakshi

March 27, 2024 | 1:18 pm

OXBR

Oxbridge Re Holdings Limited (OXBR) announced the launch of 'EpsilonCat Re', a tokenized real-world asset offering through its subsidiary SurancePlus Inc. The offering involves issuing 500,000 to 1,000,000 digital token participation shares at $10 each, with proceeds used to purchase participating notes for collateralized reinsurance contracts. The EpsilonCat Re tokens target an annualized return of 42%, with last year's DeltaCat Re tokens exceeding expectations. OXBR's venture into RWA tokenization aligns with broader financial trends, including Blackrock's plan to tokenize $10 trillion of assets.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:17 pm